免疫检查点抑制剂所致肝损伤患者肝胆系统的计算机断层扫描表现
本研究为单中心回顾性研究,纳入2020年1月至2021年12月间19例免疫检查点抑制剂所致肝损伤并接受CT检查的患者,由两名放射科医师独立评估治疗前与肝损伤发生时的CT表现。结果显示,胆道异常(如胆管扩张、胆管壁增厚)的发生率高于肝脏异常,单纯胆管炎最常见(36.8%),其次为重叠型(26.3%)和单纯肝炎(26.3%)。作者结论认为免疫检查点抑制剂所致肝损伤在CT上胆道异常较肝脏异常更常见,但需更大样本研究验证。
要点
- 免疫检查点抑制剂所致肝损伤在CT上以胆道异常多见,胆管扩张占63.2%、胆管壁增厚占60%。
- 肝损伤发生时可见非水肿性胆囊壁增厚(57.9%)、肝大(42.1%)、门周水肿(31.6%)等表现。
- 按CT表现分类,单纯胆管炎最常见(36.8%),其次为重叠型(26.3%)和单纯肝炎(26.3%)。
核心结论
- 免疫检查点抑制剂所致肝损伤患者在CT图像上胆道异常的发生率高于肝脏异常;作者指出未来需更大样本研究验证这些发现。
研究设计与样本
- 单中心回顾性研究,纳入2020年1月至2021年12月间19例免疫检查点抑制剂所致肝损伤并接受CT检查的患者,由两名委员会认证的放射科医师独立评估ICI治疗前(pre-CT)与肝损伤发生时(post-CT)的CT图像,判断有无提示肝炎和胆管炎的影像表现,并据此将肝损伤分为单纯肝炎、单纯胆管炎和重叠型(胆管炎加肝炎)三类。
关键影像表现/征象
- post-CT显示胆管扩张12例(63.2%)、胆管壁增厚9例(60%)、非水肿性胆囊壁增厚11例(57.9%)、肝大8例(42.1%)、门周水肿6例(31.6%)、胆囊壁水肿2例(10.5%)。
- 胆管壁增厚位于肝门周围胆管者占53.3%、远端胆管者占60%、胰内胆管者占46.7%、胆囊管者占26.7%。
诊断标准与关键数值
- 根据CT表现将ICI所致肝损伤分为三类:单纯肝炎、单纯胆管炎和重叠型(胆管炎加肝炎)。
- 分类结果:单纯胆管炎最常见(36.8%),其次为重叠型(26.3%)和单纯肝炎(26.3%)。
临床应用与阅片要点
- 在免疫检查点抑制剂治疗患者出现肝损伤时,阅片应关注胆管扩张、胆管壁增厚及非水肿性胆囊壁增厚等胆道异常征象。
- 同时注意肝大、门周水肿和胆囊壁水肿等肝脏及胆囊表现,并按单纯肝炎、单纯胆管炎或重叠型进行分类描述。
局限性
- 本研究为单中心回顾性研究。
- 样本量较小(共19例患者)。
- 作者指出未来需更大样本研究验证这些发现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: The incidence of immune checkpoint inhibitor (ICI)-induced liver injury has increased recently; however, its imaging characteristics remain unclear. This study aimed to characterize the computed tomography (CT) findings of ICI-induced liver injury.
METHODS: This was a single-center retrospective study of patients with ICI-induced liver injury who underwent CT between January 2020 and December 2021. Two board-certified radiologists independently evaluated the CT findings of the patients before the start of ICI therapy (pre-CT) and at the onset of ICI-induced liver injury (post-CT) to determine the presence or absence of imaging findings suggestive of hepatitis and cholangitis. ICI-induced liver injury was classified into three categories based on the CT findings: hepatitis alone, cholangitis alone, and overlapped (cholangitis plus hepatitis).
RESULTS: A total of 19 patients were included in this study. Bile duct dilatation, bile duct wall thickening, non-edematous gallbladder wall thickening, hepatomegaly, periportal edema, and gallbladder wall edema were observed in the post-CT images of 12 (63.2%), 9 (60%), 11 (57.9%), 8 (42.1%), 6 (31.6%), and 2 (10.5%) patients, respectively. Wall thickening in the perihilar, distal, intrapancreatic bile duct and the cystic duct were observed in 53.3%, 60%, 46.7%, and 26.7% of the study population, respectively. Regarding the classification of ICI-induced liver injury, cholangitis alone was most common (36.8%), followed by overlapped (26.3%) and hepatitis alone (26.3%).
CONCLUSIONS: Patients with ICI-induced liver injury demonstrated a higher incidence of biliary abnormalities than hepatic abnormalities on CT images; nonetheless, future studies with larger sample sizes are needed to validate these findings.
引用
- Masuoka, Hiyama, Kuno, et al. Computed tomography findings of hepatobiliary systems in patients with immune checkpoint inhibitor-induced liver injury. Abdom Radiol (NY). 2023. PMID: 37294454. doi:10.1007/s00261-023-03967-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。